The Chelsea Critical Care Consortium LLP OC445124 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is that of provision of medical services. Digita Accounts Production Advanced 6.30.9574.0 true OC445124 2025-04-01 2026-03-31 OC445124 2026-03-31 OC445124 core:CurrentFinancialInstruments 2026-03-31 OC445124 core:WithinOneYear 2026-03-31 OC445124 bus:SmallEntities 2025-04-01 2026-03-31 OC445124 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 OC445124 bus:FilletedAccounts 2025-04-01 2026-03-31 OC445124 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 OC445124 bus:RegisteredOffice 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP11 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP12 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP13 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP14 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP15 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP17 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP18 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP2 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP3 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP4 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP5 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP7 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP8 2025-04-01 2026-03-31 OC445124 bus:PartnerLLP9 2025-04-01 2026-03-31 OC445124 bus:LimitedLiabilityPartnershipLLP 2025-04-01 2026-03-31 OC445124 countries:AllCountries 2025-04-01 2026-03-31 OC445124 2024-04-01 2025-03-31 OC445124 2025-03-31 OC445124 core:CurrentFinancialInstruments 2025-03-31 OC445124 core:WithinOneYear 2025-03-31 iso4217:GBP xbrli:pure

Registration number: OC445124

The Chelsea Critical Care Consortium LLP
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2026

The Chelsea Critical Care Consortium LLP

Contents

Limited liability partnership information | 1
Financial Statements | 2 to 5
Balance Sheet | 2
Notes to the Financial Statements | 3

The Chelsea Critical Care Consortium LLP

Limited liability partnership information

Designated members | Alice Mary Sisson Roger Davies

Members | Marcela Vizcaychipi Richard Timothy Keays Sanjeet Chana Dilshad Valliani Abigail Catherine Dias Zdenek Bares Linsey Emma Christie Jm Medical Services Ltd Respiratorydoc Ltd Sampath Weerakkody Jason Tatlock Michelle Hayes

Registered office | 5th floor Chelsea & Westminster Hospital 369 Fulham Road London SW10 9NH

Accountants | Michaelides Warner & Co 102 Fulham Palace Road London W6 9PL

The Chelsea Critical Care Consortium LLP

(Registration number: OC445124)
Balance Sheet as at 31 March 2026

| Note | 2026 £ | 2025 £
Current assets |  |  |
Debtors | 3 | 29,475 | -
Cash and short-term deposits |  | 80,088 | 44,215
|  | 109,563 | 44,215
Creditors: Amounts falling due within one year | 4 | (2,800) | (6,500)
Net assets attributable to members |  | 106,763 | 37,715
Represented by: |  |  |
Loans and other debts due to members |  |  |
Members' capital classified as a liability |  | 106,763 | 37,715
|  | 106,763 | 37,715
Total members' interests |  |  |
Loans and other debts due to members |  | 106,763 | 37,715
|  | 106,763 | 37,715

For the year ending 31 March 2026 the limited liability partnership was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied to limited liability partnerships, relating to small entities.

These financial statements have been prepared and delivered in accordance with the provisions applicable to limited liability partnerships subject to the small limited liability partnerships regime. As permitted by section 444 (5A) of the Companies Act 2006, the members have not delivered to the registrar a copy of the Profit and Loss Account.

The members acknowledge their responsibilities for complying with the requirements of the Act, as applied to limited liability partnerships by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 with respect to accounting records and the preparation of accounts.

The financial statements of The Chelsea Critical Care Consortium LLP (registered number OC445124) were approved by the Board and authorised for issue on 30 June 2026. They were signed on behalf of the limited liability partnership by:

......................................... Roger Davies Designated member

The Chelsea Critical Care Consortium LLP

Notes to the Financial Statements for the Year Ended 31 March 2026

1 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

General information and basis of accounting

The limited liability partnership is incorporated in England and Wales under the Limited Liability Partnership Act 2000. The address of the registered office is given on the limited liability partnership information page. The nature of the limited liability partnership’s operations and its principal activities are given in the members’ report.
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
The functional currency of The Chelsea Critical Care Consortium LLP is considered to be pounds sterling because that is the currency of the primary economic environment in which the limited liability partnership operates. Foreign operations are included in accordance with the policies set out below.

Revenue recognition

Revenue is recognised to the extent that the limited liability partnership obtains the right to consideration in exchange for its performance. Revenue is measured at the fair value of the consideration received, excluding discounts, rebates, VAT and other sales tax or duty.

Members' remuneration and division of profits

The SORP recognises that the basis of calculating profits for allocation may differ from the profits reflected through the financial statements prepared in compliance with recommended practice, given the established need to seek to focus profit allocation on ensuring equity between different generations and populations of members.
Consolidation of the results of certain subsidiary undertakings, the provision for annuities to current and former members, pension scheme charges, the spreading of acquisition integration costs and the treatment of long leasehold interests are all items which may generate differences between profits calculated for the purpose of allocation and those reported within the financial statements. Where such differences arise, they have been included within other amounts in the balance sheet.
Members' fixed shares of profits (excluding discretionary fixed share bonuses) and interest earned on members' balances are automatically allocated and, are treated as members' remuneration charged as an expense to the profit and loss account in arriving at profit available for discretionary division among members.
The remainder of profit shares, which have not been allocated until after the balance sheet date, are treated in these financial statements as unallocated at the balance sheet date and included within other reserves.

The Chelsea Critical Care Consortium LLP

Notes to the Financial Statements for the Year Ended 31 March 2026

Taxation

The taxation payable on the partnership's profits is the personal liability of the members, although payment of such liabilities is administered by the partnership on behalf of its members. Consequently, neither partnership taxation nor related deferred taxation is accounted for in these financial statements. Sums set aside in respect of members' tax obligations are included in the balance sheet within loans and other debts due to members, or are set against amounts due from members as appropriate.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the limited liability partnership will not be able to collect all amounts due according to the original terms of the receivables.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the limited liability partnership does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Members' interests

Amounts due to members after more than one year comprise provisions for annuities to current members and certain loans from members which are not repayable within twelve months of the balance sheet date.

Financial instruments

Classification

All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a finance transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Financial assets and liabilities are only offset in the balance sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the limited liability partnership intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

The Chelsea Critical Care Consortium LLP

Notes to the Financial Statements for the Year Ended 31 March 2026

2 | Particulars of employees

The average number of persons employed by the limited liability partnership during the year was 0 (2025 - 0).

3 | Debtors

| 2026 £
Trade debtors | 29,475
Total current trade and other debtors | 29,475

4 | Creditors: Amounts falling due within one year

| 2026 £ | 2025 £
Trade creditors | - | 3,700
Accruals and deferred income | 2,800 | 2,800
| 2,800 | 6,500

5 | Control

The members are the controlling party by virtue of their controlling interest in the limited liability partnership. The ultimate controlling party is the same as the controlling party.